US 11,752,075 B2
Oral care compositions
Dennis Zhang, Piscataway, NJ (US); Luciana Rinaudi Marron, Somerset, NJ (US); Stacey Lavender, Chesterfield, NJ (US); Lauren Evans, Highland Park, NJ (US); Neeta Atul Patel, Monmouth Junction, NJ (US); Venda Porter Maloney, Metuchen, NJ (US); and Alice Ng, Livingston, NJ (US)
Assigned to Colgate-Palmolive Company, New York, NY (US)
Filed by Colgate-Palmolive Company, New York, NY (US)
Filed on May 24, 2022, as Appl. No. 17/752,543.
Claims priority of provisional application 63/221,703, filed on Jul. 14, 2021.
Claims priority of provisional application 63/192,876, filed on May 25, 2021.
Prior Publication US 2022/0387273 A1, Dec. 8, 2022
Int. Cl. A61K 8/27 (2006.01); A61K 8/21 (2006.01); A61K 8/46 (2006.01); A61Q 11/00 (2006.01)
CPC A61K 8/27 (2013.01) [A61K 8/21 (2013.01); A61K 8/466 (2013.01); A61Q 11/00 (2013.01)] 14 Claims
 
1. An oral care composition comprising:
a source of zinc ions comprising zinc citrate and zinc oxide, wherein the zinc citrate is in an amount from 0.25% to 1.0% by wt. and zinc oxide is present in an amount of from 0.75% to 1.25% by wt. based on the weight of the oral care composition,
a source of fluoride, wherein the source of fluoride comprises sodium fluoride in an amount from 0.2% to 2% by weight, relative to the weight of the oral care composition;
an effective amount of a zwitterionic surfactant, wherein the zwitterionic surfactant comprises cocamidopropyl betaine in an amount from 0.5%-5% by wt. of the composition; and
an effective amount of a taurate surfactant, wherein the taurate surfactant comprises sodium methyl cocoyl taurate in an amount from 0.25% to 5% by weight of the composition.